Deutsche Bank
MIRM icon

Deutsche Bank’s Mirum Pharmaceuticals MIRM Stock Holding History

Deutsche Bank’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.55M Buy
81,586
+31,541
+63% +$3.17M ﹤0.01% 1084
2026
Q1 		$4.62M Sell
50,045
-136,667
-73% -$12.9M ﹤0.01% 1335
2025
Q4 		$14.7M Buy
186,712
+2,382
+1% +$171K ﹤0.01% 969
2025
Q3 		$13.5M Buy
184,330
+28,703
+18% +$1.82M ﹤0.01% 962
2025
Q2 		$7.92M Sell
155,627
-85,117
-35% -$3.79M ﹤0.01% 1076
2025
Q1 		$10.8M Buy
240,744
+71,421
+42% +$3.37M ﹤0.01% 989
2024
Q4 		$7M Buy
169,323
+12,060
+8% +$503K ﹤0.01% 1170
2024
Q3 		$6.13M Sell
157,263
-91,788
-37% -$3.66M ﹤0.01% 1190
2024
Q2 		$8.52M Buy
249,051
+4,900
+2% +$128K ﹤0.01% 1055
2024
Q1 		$6.13M Buy
244,151
+72,625
+42% +$2M ﹤0.01% 1182
2023
Q4 		$5.06M Buy
171,526
+157,162
+1,094% +$4.76M ﹤0.01% 1252
2023
Q3 		$454K Sell
14,364
-97,047
-87% -$2.66M ﹤0.01% 2229
2023
Q2 		$2.88M Buy
111,411
+48,020
+76% +$1.28M ﹤0.01% 1455
2023
Q1 		$1.52M Buy
63,391
+4,256
+7% +$97K ﹤0.01% 1836
2022
Q4 		$1.15M Buy
59,135
+51,123
+638% +$1.01M ﹤0.01% 1962
2022
Q3 		$168K Sell
8,012
-68,013
-89% -$1.64M ﹤0.01% 3043
2022
Q2 		$1.48M Buy
76,025
+5,994
+9% +$141K ﹤0.01% 1930
2022
Q1 		$1.54M Sell
70,031
-240
-0.3% -$4.9K ﹤0.01% 2051
2021
Q4 		$1.12M Sell
70,271
-9,755
-12% -$152K ﹤0.01% 2371
2021
Q3 		$1.59M Sell
80,026
-62
-0.1% -$1.01K ﹤0.01% 2285
2021
Q2 		$1.39M Sell
80,088
-1,237
-2% -$22.2K ﹤0.01% 2567
2021
Q1 		$1.61M Buy
81,325
+9,545
+13% +$183K ﹤0.01% 2333
2020
Q4 		$1.25M Buy
71,780
+69,135
+2,614% +$1.36M ﹤0.01% 2297
2020
Q3 		$51K Buy
2,645
+252
+11% +$5.41K ﹤0.01% 3885
2020
Q2 		$47K Buy
2,393
+743
+45% +$12.4K ﹤0.01% 3847
2020
Q1 		$23K Buy
1,650
+753
+84% +$12.4K ﹤0.01% 3879
2019
Q4 		$21K Buy
897
+185
+26% +$1.97K ﹤0.01% 4291
2019
Q3 		$6K Buy
+712
New +$8.73K ﹤0.01% 4625

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Deutsche Bank's MIRM Position: Q2 2026 in Review

Deutsche Bank increased its Mirum Pharmaceuticals (MIRM) stake by 63% in Q2 2026, buying an estimated $3.17M and bringing the position to 81,586 shares worth $9.55M. The position accounts for ﹤0.01% of the portfolio, ranked #1084.

Deutsche Bank first reported a position in MIRM in Q3 2019 and has held it in 28 quarters since. The position peaked at $14.7M in Q4 2025. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Deutsche Bank held 81,586 shares of Mirum Pharmaceuticals worth $9.55M as of Q2 2026.
  • Deutsche Bank bought 31,541 Mirum Pharmaceuticals shares in Q2 2026, an estimated $3.17M.
  • Mirum Pharmaceuticals made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #1084 holding.
  • Deutsche Bank first reported a position in Mirum Pharmaceuticals in Q3 2019 and has held it in 28 quarters since.
  • Deutsche Bank's Mirum Pharmaceuticals position peaked at $14.7M in Q4 2025.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.